Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 85 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Califf RM, Woodcock J, Ostroff S. A proactive response to prescription opioid abuse. N Engl J Med 2016;374:1480-5. [Ref.ID 100231]
2. Cita con resumen
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzylio W, De Lucca P, Im K, Bohula EA, Reist CJ, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM, for the IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387-97. [Ref.ID 99298]
3.Tiene citas relacionadas Cita con resumen
Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breidthardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowtitz SD, Nessel CC, Fox KAA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Lancet 2015;385:2363-70. [Ref.ID 99291]
4. Cita con resumen
Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 2015;372:1031-9. [Ref.ID 98939]
5.Tiene citas relacionadas Cita con resumen
Reith C, Landray M, Califf RM. Randomized clinical trials - Removing obstacles. N Engl J Med 2013;369:2269. [Ref.ID 96620]
6.
Reith C, Landray M, Devereaux PJ, Bosch J, Granger CB, Baigent C, Califf RM, Collins R, Yusuf S. Randomized clinical trials - Removing unnecessary obstacles. N Engl J Med 2013;369:1061-5. [Ref.ID 96099]
7.Tiene citas relacionadas Cita con resumen
Califf RM, McCall J, Harrington RA. Assessing research results in the medical literature: trust but verify. JAMA Intern Med 2013;173:1053-5. [Ref.ID 95719]
8. Cita con resumen
Mahaffey KW, Wojdyla D, Hankey GJ, White HD, Nessel CC, Piccini JP, Patel MR, Berkowitz SD, Becker RC, Halperin JL, Singer DE, Califf RM, Fox KAA, Breithardt G, Hacke W. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. Ann Intern Med 2013;158:861-8. [Ref.ID 95680]
9.Tiene citas relacionadas Cita con resumen
Hirsch BR, Califf RM, Cheng SK, Tasneem A, Horton J, Chiswell K, Schulman KA, Dilts DM, Abemethy AP. Characteristics of oncology clinical trials: insights from a systematic analysis of Clinical Trials.gov. JAMA Intern Med 2013;173:972-9. [Ref.ID 95611]
10.Tiene citas relacionadas Cita con resumen
Inrig JK, Barnhart HX, Reddan D, Patel UD, Sapp S, Califf RM, Singh AK, Szczech LA. Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis 2012;60:390-41. [Ref.ID 92942]
11.Tiene citas relacionadas Cita con resumen
Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in clinicalTrials.gov, 2007-2010. JAMA 2012;307:1838-47. [Ref.ID 92856]
12.Tiene citas relacionadas Cita con resumen
Patel MR, Fox KAA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. Author/editor response. N Engl J Med 2011;365:2335. [Ref.ID 91975]
13.Tiene citas relacionadas Cita con resumen
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithard G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JP, Berkowitz SD, Fox KAA, Califf RM, for the ROCKET AF investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91. [Ref.ID 90982]
14.Tiene citas relacionadas
O'Connor CM, Starling RC, Hernandez AF, Dickstein AK, Hasselblad V, Heizer GM, Massie BM, McMurray JJV, Nieminen MS, Reist CJ, Rouleau RJL, Swedberg K, Adams Jr KF, Battler AA, Botero R, Bohidar NR, Clausell BN, Corbalán NCR, Costanzo MR, Dahlstrom U, Deckelbaum Li, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois FD, Méndez SS, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski PP, Tang WHW, Tanomsup S, Teerlink JR, Triposkjadis F, Troughton RW, Voors AA, Whellan DJ, Zannad WF, Califf RM. Effect of nesiritide in patients with acute decomensated heart failure. N Engl J Med 2011;365:32-43. [Ref.ID 90905]
15.Tiene citas relacionadas Cita con resumen
Zarín DA, Tse T, Williams RJ, Califf RM, Ide NC. The clinicalTrials.gov results database - Update and key issues. N Engl J Med 2011;364:852-60. [Ref.ID 90491]
16.Enlace a cita original Cita con resumen
Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009;54:1089-95. [Ref.ID 86784]
17. Cita con resumen
Califf RM, Harrington RA, Blazing MA. Premature release of data from clinical trials of ezetimibe. N Engl J Med 2009;361:712-7. [Ref.ID 86530]
18.Tiene citas relacionadas Cita con resumen
Tricoci P, Allen JM, Kramer JM, Califf RM, Smith Jr SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41. [Ref.ID 85336]
19. Cita con resumen
O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishman RR. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008;168:2232-7. [Ref.ID 84498]
Seleccionar todas
 
 1 a 20 de 85 siguiente >>